ENDPOINTS

Live updates: Makary likely a lock for next FDA chief after breezy Senate hearing

2 months ago

People

Pharma

Bristol Myers' MyoKardia unit ends work with Fulcrum; ALX discloses layoffs

2 months ago

News Briefing

Live updates: Trump NIH pick Bhattacharya sails through Senate hearing, sidestepping controversy

2 months ago

People

Pharma

Tenaya raises about $53M; BeiGene’s PD-1 gets a first-line approval

2 months ago

News Briefing

Genentech's TNKase gets new approval; Sanofi gives up rights to oncology candidate

2 months ago

News Briefing

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

2 months ago

News Briefing

Hansoh ends collaboration with Silence; Vir hunts for HBV drug partner

2 months ago

News Briefing

Harbour BioMed inks deal up to $395M; ORIC refines plans for two drugs

2 months ago

News Briefing

Repare to lay off 75% of staff; Castle Creek inks $75M royalty deal

2 months ago

News Briefing

FDA won’t allow Invivyd’s Pemgarda to treat Covid; Antibiotic biotech launches

3 months ago

News Briefing

More biotechs announce share buybacks; Cosette to buy Mayne Pharma

3 months ago

News Briefing

Illumina to lay off about 100 people; Incyte’s new AI partnership

3 months ago

News Briefing

Another Chinese biotech files to go public in Hong Kong; A new ROR1 ADC deal

3 months ago

News Briefing

Septerna ends Phase 1 trial for hypoparathyroidism drug; Sanofi’s Merilog is approved

3 months ago

News Briefing

Otsuka makes pipeline changes; Oculis reveals $100M offering

3 months ago

News Briefing

David Schenkein resigns from Agios’ board; Moderna hires Roivant exec as chief marketing officer

3 months ago

Peer Review

Allay Therapeutics raises $45M for ongoing Series D; Encoded’s layoffs

3 months ago

News Briefing

Biogen downplays capacity for M&A; Roche’s SMA drug is approved as a tablet

3 months ago

News Briefing

IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third Harmonic

3 months ago

News Briefing

Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal

3 months ago

News Briefing

AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’s

3 months ago

News Briefing

Turnstone stops TIL studies; GH Research’s $150M offering

3 months ago

News Briefing

Tectonic to raise $185M; Acelyrin drops rights to Affibody drug

3 months ago

News Briefing

Ironwood's layoffs; Shionogi’s RSV pill succeeds in Phase 2

3 months ago

News Briefing

about the author

author articles

Live updates: Makary likely a lock for next FDA chief after breezy Senate hearing

Bristol Myers' MyoKardia unit ends work with Fulcrum; ALX discloses layoffs

Live updates: Trump NIH pick Bhattacharya sails through Senate hearing, sidestepping controversy

Tenaya raises about $53M; BeiGene’s PD-1 gets a first-line approval

Genentech's TNKase gets new approval; Sanofi gives up rights to oncology candidate

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

Hansoh ends collaboration with Silence; Vir hunts for HBV drug partner

Harbour BioMed inks deal up to $395M; ORIC refines plans for two drugs

Repare to lay off 75% of staff; Castle Creek inks $75M royalty deal

FDA won’t allow Invivyd’s Pemgarda to treat Covid; Antibiotic biotech launches

More biotechs announce share buybacks; Cosette to buy Mayne Pharma

Illumina to lay off about 100 people; Incyte’s new AI partnership

Another Chinese biotech files to go public in Hong Kong; A new ROR1 ADC deal

Septerna ends Phase 1 trial for hypoparathyroidism drug; Sanofi’s Merilog is approved

Otsuka makes pipeline changes; Oculis reveals $100M offering

David Schenkein resigns from Agios’ board; Moderna hires Roivant exec as chief marketing officer

Allay Therapeutics raises $45M for ongoing Series D; Encoded’s layoffs

Biogen downplays capacity for M&A; Roche’s SMA drug is approved as a tablet

IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third Harmonic

Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal

AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’s

Turnstone stops TIL studies; GH Research’s $150M offering

Tectonic to raise $185M; Acelyrin drops rights to Affibody drug

Ironwood's layoffs; Shionogi’s RSV pill succeeds in Phase 2